New Key Statistics Module, Z-Score and F-Score
AMEX:NBY Key Ratios
| Market Cap $ M | 4.99 |
| Enterprise Value $ M | 7.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.05 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 14.00 |
| EPS (TTM) $ | -2.61 |
| Beneish M-Score | -4.36 |
| 10-y EBITDA Growth Rate % | 42.00 |
| 5-y EBITDA Growth Rate % | 37.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.25 |
| EV-to-EBITDA | -1.29 |
| PEG | -- |
| Shares Outstanding M | 37.83 |
| Net Margin (%) | -78.09 |
| Operating Margin % | -34.01 |
| Pre-tax Margin (%) | -77.22 |
| Quick Ratio | 0.75 |
| Current Ratio | 0.92 |
| ROA % (ttm) | -95.69 |
| ROE % (ttm) | -198.74 |
| ROIC % (ttm) | -70.60 |
| Dividend Yield % | -- |
| Altman Z-Score | -49.94 |
NBY Number of Guru Trades
NBY Volume of Guru Trades
Gurus Latest Trades with AMEX:NBY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:NBY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NovaBay Pharmaceuticals Inc Insider Transactions
No Available Data
News about AMEX:NBY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers